Multidrug therapy for polycystic kidney disease: a review and perspective. - Wikidata - wikimedia - TriplyDB

Multidrug therapy for polycystic kidney disease: a review and perspective.

Multidrug therapy for polycystic kidney disease: a review and perspective.

http://www.wikidata.org/entity/Q38083427

about

Role of calcium in polycystic kidney disease: From signaling to pathology ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with Vasopressin Signaling and Apoptosis In Vivo in Mice Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney disease.Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.Evidence for a role of proteins, lipids, and phytochemicals in the prevention of polycystic kidney disease progression and severity.Clinical Trials and a View Toward the Future of ADPKD.Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.Role of extracellular ATP and P2 receptor signaling in regulating renal cyst growth and interstitial inflammation in polycystic kidney disease.Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease.

P2860

Q26770740-4142F756-0A48-4B20-A9F0-B5FBC9373A38 Q27321009-24665102-2341-442E-B3A7-1A0ADAC4EA78 Q35531700-D8107DE3-0BB7-42F6-B841-AE64A9CE4883 Q36167611-6F50BD2E-3578-4B90-A1E3-4D6FBCD39336 Q38163610-254A5221-4431-4A98-936F-97B90CF9847D Q38812543-6E7BA58A-2469-4102-857D-3EAB84D77D6B Q39189000-D0288031-F5F3-4EDD-8B99-BFBFC8735E5B Q42556886-D45692D0-4104-47C7-AE77-F23D7CD26229 Q51712681-133DEFC4-FB1B-46EA-B23D-D861889F25CD Q54976505-AE18B1C4-3A5E-4C4A-9A08-26975C8E09BB

P2860

Multidrug therapy for polycystic kidney disease: a review and perspective.

http://www.wikidata.org/entity/Q38083427

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Multidrug therapy for polycystic kidney disease: a review and perspective.

@en

type

label

Multidrug therapy for polycystic kidney disease: a review and perspective.

@en

prefLabel

Multidrug therapy for polycystic kidney disease: a review and perspective.

@en

P1433

Q38083427-184BABD1-897A-4F01-B9AA-E57540406F74

P1476

Q38083427-B3C14AD0-580D-4CF8-8D58-0E0EED1661F0

P2093

Q38083427-025CEC1A-CB2A-4433-AFF6-73284C244B07

Q38083427-49890657-CB1B-43D1-BB9F-E891040AFE42

Q38083427-90C08329-19DD-4FA7-9B76-302C23C4624F

P2860

Q38083427-05303A43-A271-42F8-93E0-3A3791128473

Q38083427-07CC7254-C02C-4F15-8CE9-F2367941296C

Q38083427-0CD49950-22B4-47DD-90C0-1773029CC3B4

Q38083427-0F997821-8471-41C7-804F-015E3737CDF1

Q38083427-198B870E-ED18-4A7F-92FD-82DC35A6E0FD

Q38083427-1D45923C-3A07-4D38-8E99-49EF576EFA61

Q38083427-1E795BA8-6A79-416F-BB6E-9E58E703F058

Q38083427-1F927900-FDBF-42D7-AD48-120DAFDCA6FD

Q38083427-3610DF49-C14C-4DD2-A498-C64B2DD601F6

Q38083427-398AE660-378C-4512-BD91-27A5824DF229

P304

Q38083427-D31AE4F0-26C2-4365-AA4F-0532C0094BE8

P31

Q38083427-5C1F5288-3C4F-4F4B-BC12-2BA40EC07A20

P356

Q38083427-24D8381C-90DF-42B5-810E-3D248246D088

P433

Q38083427-98D7D92E-BEBB-4985-81AB-AB3AB9C61601

P478

Q38083427-66B6AA14-8997-41C2-A337-422B0B9585AE

P577

Q38083427-6A7053E7-B93E-440D-81B0-A4CBA9A7D08C

P698

Q38083427-FC10513B-7A5D-4A6B-BE1B-67CE9B37F4ED

P356

P1433

American Journal of Nephrology

P1476

Multidrug therapy for polycystic kidney disease: a review and perspective.

@en

P2093

Gianluca Aguiari

http://www.w3.org/2001/XMLSchema#string

Laura Del Senno

http://www.w3.org/2001/XMLSchema#string

Luigi Catizone

http://www.w3.org/2001/XMLSchema#string

P2860

Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR

Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells

Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential.

A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease.

Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide.

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.

Sirolimus therapy to halt the progression of ADPKD.

Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1.

P304

175-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000346812

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23428809

http://www.w3.org/2001/XMLSchema#string